John R. Vane

Also known as

John R. VaneSir John VaneJ. R. VaneJ.R. VaneJohn VaneSir John R. VaneSir John R VaneSir John Robert Vane FRS

British pharmacologist who was instrumental in the understanding of how aspirin produces pain-relief and anti-inflammatory effects and his work led to new treatments for heart and blood vessel disease and introduction of ACE inhibitors.

Born 1927-02-01

Died 2004-02-01

Identifiers

Open LibraryOL342185A

Top Subjects

Pharmacology (3)
Arachidonic Acids (1)
Epoprostenol (1)
Nonsteroidal anti-inflammatory agents -- Physiological effect -- Congresses (1)
Nonsteroidal anti-inflammatory agents -- Side effects -- Congresses (1)
Cyclooxygenases -- Inhibitors -- Congresses (1)
Surgery (1)

Books by John R. Vane

Total count: 14

Anti-Inflammatory Drugs

Springer1978-12-01
Prostacyclin in health and diseaseLilly lecture, 1981, delivered on 4th December, 1981, in the Hall of the Royal College of Physicians of Edinburgh

Royal College of Physicians of Edinburgh1982-01-01
Therapeutic Application of Prostaglandins

Arnold1993-07-01
Improved Non-Steroid Anti-Inflammatory DrugsCox-2 Enzyme Inhibitors

Island Press1996-01-01
Improved non-steroid anti-flammatory drugs COX-2 enzyme inhibitorsproceedings of a conference held on October 10-11, 1995, at Regent's College, London

Kluwer Academic Publishers1996-01-01
New Targets in Inflammation

Island Press1996-01-01
Eicosanoids, Aspirin, and Asthma

Taylor & Francis Group1998-01-01
Clinical Significance And Potential Of Selective Cox-2 Inhibitors1 edition

WILLIAM HARVEY PRESS1998-01-01
Clinician's Manual on COX-2 Inhibition2nd edition

Science Press Inc.1999-01-01
Therapeutic Roles Of Selective Cox-2 Inhibitors1 edition

WILLIAM HARVEY PRESS2001-01-01
Selective COX-2 InhibitorsPharmacology, Clinical Effects and Therapeutic Potential

Springer2012-01-01
New Targets in InflammationInhibitors of COX-2 or Adhesion Molecules Proceedings of a Conference Held on April 15-16, 1996, in New Orleans, USA, Supported by an Educational Grant from Boehringer Ingelheim

Springer2012-01-01
Selective COX-2 Inhibitors

Springer2012-11-05
Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research

Springer2013-01-01